Proceedings of a symposium: economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful health economic study for the pharmaceutical industry?
Gagnon
J P
JP
Hoechst Marion Roussel, Inc., Kansas City, MO 64134-0627, USA.
D002317:Cardiovascular Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000191:economics; D003365:Costs and Cost Analysis; D019049:Developed Countries; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D017850:Economics, Pharmaceutical; D019981:Health Care Sector; D006301:Health Services Needs and Demand / Q000191:economics; D006302:Health Services Research / Q000191:economics*; D006801:Humans; D012106:Research; D011795:Surveys and Questionnaires
D002317:Cardiovascular Agents